DOI: 10.1001/jamaoto.2023.1729 ISSN: 2168-6181
Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto, Priyadharsini Nagarajan, Jacob M. Maronge, Jason M. Johnson, David I. Rosenthal, Jeffrey N. Myers, Neil D. Gross- Otorhinolaryngology
- Surgery
This secondary analysis of a phase 2 clinical trial examines long-term survival for resectable cutaneous squamous cell carcinoma of the head and neck according to pathologic response.